| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.706 | 0.023 | 0.78 | Caspase 9 stimulant | 0.78 0.014 DBMET01678 0.658 0.029 DBMET01679 | DBMET01678 | |
| 0.655 | 0.005 | 0.709 | Dyrk kinase inhibitor | 0.64 0.005 DBMET01678 0.709 0.005 DBMET01679 | DBMET01679 | |
| 0.636 | 0.005 | 0.698 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.629 0.005 DBMET01678 0.698 0.005 DBMET01679 | DBMET01679 | |
| 0.6 | 0.007 | 0.707 | GABA C receptor rho-3 antagonist | 0.51 0.023 DBMET01678 0.707 0.003 DBMET01679 | DBMET01679 | |
| 0.544 | 0.014 | 0.581 | Calcium channel L-type activator | 0.53 0.018 DBMET01678 0.581 0.008 DBMET01679 | DBMET01679 | |
| 0.51 | 0.029 | 0.51 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.393 0.107 DBMET01678 0.506 0.031 DBMET01679 | ||
| 0.482 | 0.006 | 0.482 | Calcium channel activator | 0.453 0.011 DBMET01678 0.438 0.014 DBMET01679 | ||
| 0.502 | 0.027 | 0.535 | 5 Hydroxytryptamine release stimulant | 0.503 0.027 DBMET01678 0.535 0.022 DBMET01679 | DBMET01679 | |
| 0.467 | 0.028 | 0.467 | MAP kinase kinase 6 inhibitor | 0.413 0.051 DBMET01678 0.467 0.028 DBMET01679 | ||
| 0.437 | 0.015 | 0.45 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.433 0.015 DBMET01678 0.45 0.013 DBMET01679 | DBMET01679 | |
| 0.431 | 0.032 | 0.431 | Aryl hydrocarbon receptor agonist | 0.406 0.036 DBMET01678 0.372 0.043 DBMET01679 | ||
| 0.394 | 0.007 | 0.394 | Phosphodiesterase inhibitor | 0.345 0.01 DBMET01678 0.259 0.02 DBMET01679 | ||
| 0.436 | 0.057 | 0.5 | Histamine release inhibitor | 0.49 0.032 DBMET01678 0.5 0.029 DBMET01679 | DBMET01679 | |
| 0.386 | 0.009 | 0.402 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.384 0.01 DBMET01678 0.402 0.008 DBMET01679 | DBMET01679 | |
| 0.371 | 0.028 | 0.454 | Antimitotic | 0.454 0.017 DBMET01678 0.266 0.054 DBMET01679 | DBMET01678 | |
| 0.36 | 0.023 | 0.444 | Cyclic AMP phosphodiesterase inhibitor | 0.444 0.011 DBMET01678 0.36 0.023 DBMET01679 | DBMET01678 | |
| 0.427 | 0.09 | 0.452 | MAP kinase 1 inhibitor | 0.452 0.077 DBMET01678 0.316 0.164 DBMET01679 | DBMET01678 | |
| 0.408 | 0.073 | 0.443 | 5 Hydroxytryptamine release inhibitor | 0.377 0.093 DBMET01678 0.443 0.055 DBMET01679 | DBMET01679 | |
| 0.36 | 0.029 | 0.376 | Psychostimulant | 0.336 0.034 DBMET01678 0.376 0.027 DBMET01679 | DBMET01679 | |
| 0.334 | 0.004 | 0.371 | GABA C receptor rho-2 antagonist | 0.303 0.005 DBMET01678 0.371 0.004 DBMET01679 | DBMET01679 | |
| 0.328 | 0.01 | 0.354 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.31 0.014 DBMET01678 0.354 0.008 DBMET01679 | DBMET01679 | |
| 0.359 | 0.07 | 0.419 | Vasodilator, peripheral | 0.419 0.049 DBMET01678 0.348 0.075 DBMET01679 | DBMET01678 | |
| 0.307 | 0.018 | 0.424 | Tubulin antagonist | 0.424 0.011 DBMET01678 0.19 0.04 DBMET01679 | DBMET01678 | |
| 0.296 | 0.01 | 0.296 | CDC-like kinase 1 inhibitor | 0.25 0.018 DBMET01678 0.278 0.013 DBMET01679 | ||
| 0.329 | 0.047 | 0.41 | DNA damaging | 0.41 0.026 DBMET01678 0.336 0.045 DBMET01679 | DBMET01678 | |
| 0.314 | 0.035 | 0.566 | Peroxidase inhibitor | 0.475 0.012 DBMET01678 0.566 0.005 DBMET01679 | DBMET01679 | |
| 0.306 | 0.03 | 0.433 | Tyrosine 3 hydroxylase inhibitor | 0.335 0.02 DBMET01678 0.433 0.005 DBMET01679 | DBMET01679 | |
| 0.276 | 0.014 | 0.276 | Interleukin 1 antagonist | 0.254 0.018 DBMET01678 0.257 0.017 DBMET01679 | ||
| 0.352 | 0.098 | 0.482 | 15-Lipoxygenase inhibitor | 0.482 0.045 DBMET01678 0.433 0.06 DBMET01679 | DBMET01678 | |
| 0.303 | 0.052 | 0.361 | Tumour necrosis factor alpha release inhibitor | 0.361 0.035 DBMET01678 0.232 0.084 DBMET01679 | DBMET01678 | |
| 0.29 | 0.039 | 0.325 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.259 0.048 DBMET01678 0.325 0.03 DBMET01679 | DBMET01679 | |
| 0.263 | 0.013 | 0.323 | Cyclin-dependent kinase 5 inhibitor | 0.229 0.017 DBMET01678 0.323 0.009 DBMET01679 | DBMET01679 | |
| 0.282 | 0.033 | 0.312 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.276 0.034 DBMET01678 0.312 0.024 DBMET01679 | DBMET01679 | |
| 0.258 | 0.011 | 0.258 | Interleukin 1b antagonist | 0.209 0.018 DBMET01678 0.196 0.02 DBMET01679 | ||
| 0.295 | 0.049 | 0.359 | Pyruvate kinase inhibitor | 0.359 0.031 DBMET01678 0.351 0.033 DBMET01679 | DBMET01678 | |
| 0.293 | 0.049 | 0.394 | Interleukin antagonist | 0.303 0.047 DBMET01678 0.394 0.032 DBMET01679 | DBMET01679 | |
| 0.257 | 0.014 | 0.257 | Alpha 2b adrenoreceptor antagonist | 0.251 0.014 DBMET01678 0.2 0.024 DBMET01679 | ||
| 0.27 | 0.027 | 0.27 | I kappa B kinase epsilon inhibitor | 0.257 0.034 DBMET01678 0.239 0.044 DBMET01679 | ||
| 0.261 | 0.018 | 0.357 | NADPH oxidase inhibitor | 0.357 0.006 DBMET01678 0.285 0.015 DBMET01679 | DBMET01678 | |
| 0.254 | 0.012 | 0.297 | Death-associated protein kinase 2 inhibitor | 0.268 0.01 DBMET01678 0.297 0.007 DBMET01679 | DBMET01679 | |
| 0.281 | 0.044 | 0.281 | Clk dual-specificity kinase inhibitor | 0.219 0.069 DBMET01678 0.251 0.055 DBMET01679 | ||
| 0.236 | 0.004 | 0.236 | Phosphodiesterase 11A inhibitor | 0.202 0.005 DBMET01678 0.208 0.004 DBMET01679 | ||
| 0.236 | 0.004 | 0.236 | Phosphodiesterase XI inhibitor | 0.202 0.005 DBMET01678 0.208 0.004 DBMET01679 | ||
| 0.362 | 0.132 | 0.489 | Apoptosis agonist | 0.489 0.078 DBMET01678 0.393 0.117 DBMET01679 | DBMET01678 | |
| 0.266 | 0.048 | 0.273 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.227 0.101 DBMET01678 0.273 0.042 DBMET01679 | DBMET01679 | |
| 0.221 | 0.005 | 0.221 | Phosphodiesterase V inhibitor | 0.178 0.007 DBMET01678 0.193 0.006 DBMET01679 | ||
| 0.269 | 0.054 | 0.269 | 5 Hydroxytryptamine 1E antagonist | 0.254 0.071 DBMET01678 0.255 0.07 DBMET01679 | ||
| 0.237 | 0.023 | 0.253 | MAO A inhibitor | 0.232 0.023 DBMET01678 0.253 0.02 DBMET01679 | DBMET01679 | |
| 0.251 | 0.037 | 0.251 | Focal adhesion kinase 2 inhibitor | 0.203 0.067 DBMET01678 0.17 0.1 DBMET01679 | ||
| 0.256 | 0.043 | 0.296 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.226 0.053 DBMET01678 0.296 0.035 DBMET01679 | DBMET01679 | |
| 0.217 | 0.005 | 0.217 | Phosphodiesterase 5A inhibitor | 0.181 0.007 DBMET01678 0.191 0.006 DBMET01679 | ||
| 0.231 | 0.021 | 0.263 | Toll-Like receptor antagonist | 0.263 0.012 DBMET01678 0.218 0.025 DBMET01679 | DBMET01678 | |
| 0.271 | 0.063 | 0.394 | Superoxide dismutase inhibitor | 0.394 0.028 DBMET01678 0.302 0.05 DBMET01679 | DBMET01678 | |
| 0.24 | 0.034 | 0.24 | Tumour necrosis factor antagonist | 0.227 0.039 DBMET01678 0.14 0.113 DBMET01679 | ||
| 0.25 | 0.046 | 0.25 | CDC-like kinase 2 inhibitor | 0.206 0.063 DBMET01678 0.243 0.048 DBMET01679 | ||
| 0.207 | 0.005 | 0.221 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.196 0.007 DBMET01678 0.221 0.005 DBMET01679 | DBMET01679 | |
| 0.216 | 0.014 | 0.216 | GABA receptor agonist | 0.181 0.023 DBMET01678 0.211 0.015 DBMET01679 | ||
| 0.202 | 0.005 | 0.222 | I kappa B kinase 1 inhibitor | 0.158 0.008 DBMET01678 0.222 0.005 DBMET01679 | DBMET01679 | |
| 0.206 | 0.015 | 0.206 | Beta amyloid protein antagonist | 0.202 0.016 DBMET01678 0.166 0.03 DBMET01679 | ||
| 0.258 | 0.068 | 0.387 | Antiamyloidogenic | 0.387 0.031 DBMET01678 0.269 0.063 DBMET01679 | DBMET01678 | |
| 0.198 | 0.01 | 0.198 | GABA A receptor agonist | 0.12 0.024 DBMET01678 0.16 0.014 DBMET01679 | ||
| 0.207 | 0.021 | 0.207 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.187 0.024 DBMET01678 0.099 0.057 DBMET01679 | ||
| 0.221 | 0.036 | 0.221 | 5 Hydroxytryptamine 3E antagonist | 0.165 0.152 DBMET01678 0.21 0.047 DBMET01679 | ||
| 0.232 | 0.047 | 0.279 | Nitric-oxide synthase stimulant | 0.279 0.018 DBMET01678 0.251 0.032 DBMET01679 | DBMET01678 | |
| 0.197 | 0.014 | 0.217 | Antineoplastic alkaloid | 0.217 0.009 DBMET01678 0.217 0.009 DBMET01679 | DBMET01679 | |
| 0.282 | 0.102 | 0.323 | Angiogenesis inhibitor | 0.323 0.082 DBMET01678 0.221 0.147 DBMET01679 | DBMET01678 | |
| 0.211 | 0.032 | 0.211 | Activin receptor-like kinase 2 inhibitor | 0.209 0.033 DBMET01678 0.167 0.055 DBMET01679 | ||
| 0.206 | 0.03 | 0.214 | Cyclin-dependent kinase 3 inhibitor | 0.184 0.045 DBMET01678 0.214 0.026 DBMET01679 | DBMET01679 | |
| 0.228 | 0.054 | 0.228 | CDC-like kinase 4 inhibitor | 0.167 0.087 DBMET01678 0.195 0.07 DBMET01679 | ||
| 0.197 | 0.025 | 0.208 | Cyclin-dependent kinase 2 inhibitor | 0.15 0.038 DBMET01678 0.208 0.023 DBMET01679 | DBMET01679 | |
| 0.198 | 0.026 | 0.214 | DNA intercalator | 0.206 0.024 DBMET01678 0.214 0.022 DBMET01679 | DBMET01679 | |
| 0.189 | 0.019 | 0.189 | 5 Hydroxytryptamine 2C antagonist | 0.113 0.039 DBMET01678 0.103 0.043 DBMET01679 | ||
| 0.231 | 0.061 | 0.261 | Platelet aggregation inhibitor | 0.261 0.047 DBMET01678 | DBMET01678 | |
| 0.208 | 0.039 | 0.208 | Vascular endothelial growth factor 3 antagonist | 0.203 0.041 DBMET01678 0.128 0.086 DBMET01679 | ||
| 0.18 | 0.013 | 0.18 | Death-associated protein kinase 1 inhibitor | 0.152 0.036 DBMET01678 0.171 0.018 DBMET01679 | ||
| 0.193 | 0.026 | 0.212 | CF transmembrane conductance regulator agonist | 0.164 0.055 DBMET01678 0.212 0.016 DBMET01679 | DBMET01679 | |
| 0.188 | 0.021 | 0.192 | MAP3K9 inhibitor | 0.179 0.028 DBMET01678 0.192 0.019 DBMET01679 | DBMET01679 | |
| 0.172 | 0.005 | 0.172 | Phosphodiesterase VI inhibitor | 0.155 0.006 DBMET01678 0.137 0.009 DBMET01679 | ||
| 0.178 | 0.011 | 0.178 | Phosphodiesterase 3A inhibitor | 0.17 0.012 DBMET01678 0.143 0.017 DBMET01679 | ||
| 0.175 | 0.009 | 0.178 | MAP-kinase-activated kinase inhibitor | 0.149 0.015 DBMET01678 0.178 0.008 DBMET01679 | DBMET01679 | |
| 0.219 | 0.061 | 0.281 | Platelet adhesion inhibitor | 0.281 0.04 DBMET01678 0.24 0.053 DBMET01679 | DBMET01678 | |
| 0.254 | 0.097 | 0.319 | Hypoxia-inducible factor 1 alpha inhibitor | 0.319 0.057 DBMET01678 0.267 0.086 DBMET01679 | DBMET01678 | |
| 0.195 | 0.039 | 0.232 | Cyclin-dependent kinase inhibitor | 0.157 0.053 DBMET01678 0.232 0.03 DBMET01679 | DBMET01679 | |
| 0.163 | 0.008 | 0.164 | MAP-kinase-activated kinase 2 inhibitor | 0.139 0.014 DBMET01678 0.164 0.008 DBMET01679 | DBMET01679 | |
| 0.21 | 0.055 | 0.21 | Histone acetyltransferase inhibitor | 0.209 0.057 DBMET01678 0.204 0.063 DBMET01679 | ||
| 0.168 | 0.015 | 0.221 | GABA C receptor rho-1 antagonist | 0.154 0.019 DBMET01678 0.221 0.005 DBMET01679 | DBMET01679 | |
| 0.174 | 0.023 | 0.182 | Platelet activating factor alpha antagonist | 0.182 0.02 DBMET01678 0.091 0.068 DBMET01679 | DBMET01678 | |
| 0.18 | 0.032 | 0.184 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.173 0.039 DBMET01678 0.184 0.029 DBMET01679 | DBMET01679 | |
| 0.187 | 0.041 | 0.187 | Toll-Like receptor 9 antagonist | 0.16 0.057 DBMET01678 0.124 0.082 DBMET01679 | ||
| 0.15 | 0.006 | 0.15 | Toll-Like receptor 7 antagonist | 0.116 0.013 DBMET01678 0.116 0.013 DBMET01679 | ||
| 0.167 | 0.026 | 0.169 | Alpha 2c adrenoreceptor antagonist | 0.169 0.025 DBMET01678 0.131 0.042 DBMET01679 | DBMET01678 | |
| 0.26 | 0.12 | 0.396 | Transcription factor NF kappa B inhibitor | 0.396 0.064 DBMET01678 0.32 0.086 DBMET01679 | DBMET01678 | |
| 0.184 | 0.046 | 0.185 | MAO inhibitor | 0.162 0.055 DBMET01678 0.185 0.046 DBMET01679 | DBMET01679 | |
| 0.217 | 0.08 | 0.217 | MAP kinase kinase 3 inhibitor | 0.19 0.155 DBMET01678 0.215 0.084 DBMET01679 | ||
| 0.175 | 0.039 | 0.247 | MAP kinase kinase inhibitor | 0.175 0.039 DBMET01678 0.247 0.016 DBMET01679 | DBMET01679 | |
| 0.187 | 0.052 | 0.215 | Protein kinase C nu inhibitor | 0.193 0.05 DBMET01678 0.215 0.042 DBMET01679 | DBMET01679 | |
| 0.214 | 0.081 | 0.274 | RNA-directed DNA polymerase inhibitor | 0.274 0.038 DBMET01678 0.263 0.043 DBMET01679 | DBMET01678 | |
| 0.172 | 0.039 | 0.172 | Aurora-B kinase inhibitor | 0.129 0.057 DBMET01678 0.123 0.062 DBMET01679 | ||
| 0.212 | 0.08 | 0.227 | EphB2 antagonist | 0.185 0.099 DBMET01678 0.227 0.07 DBMET01679 | DBMET01679 | |
| 0.138 | 0.006 | 0.138 | Phosphodiesterase II inhibitor | 0.107 0.009 DBMET01678 0.111 0.009 DBMET01679 | ||
| 0.147 | 0.016 | 0.147 | Toll-Like receptor 3 antagonist | 0.111 0.037 DBMET01678 0.098 0.055 DBMET01679 | ||
| 0.157 | 0.028 | 0.198 | Protein kinase C gamma inhibitor | 0.179 0.019 DBMET01678 0.198 0.014 DBMET01679 | DBMET01679 | |
| 0.165 | 0.037 | 0.165 | Platelet activating factor antagonist | 0.164 0.038 DBMET01678 | ||
| 0.135 | 0.009 | 0.135 | 5 Hydroxytryptamine 5 antagonist | 0.069 0.026 DBMET01678 0.084 0.019 DBMET01679 | ||
| 0.139 | 0.013 | 0.139 | Bromodomain-containing protein 2 inhibitor | 0.103 0.037 DBMET01678 0.115 0.027 DBMET01679 | ||
| 0.22 | 0.095 | 0.428 | Aldehyde oxidase inhibitor | 0.428 0.043 DBMET01678 0.404 0.046 DBMET01679 | DBMET01678 | |
| 0.217 | 0.092 | 0.273 | Vasodilator | 0.273 0.058 DBMET01678 0.237 0.077 DBMET01679 | DBMET01678 | |
| 0.213 | 0.089 | 0.281 | MAP-kinase-activated kinase 5 inhibitor | 0.235 0.069 DBMET01678 0.281 0.041 DBMET01679 | DBMET01679 | |
| 0.156 | 0.032 | 0.156 | Cyclin-dependent kinase 9 inhibitor | 0.137 0.038 DBMET01678 0.153 0.033 DBMET01679 | ||
| 0.206 | 0.086 | 0.225 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.185 0.102 DBMET01678 0.225 0.074 DBMET01679 | DBMET01679 | |
| 0.125 | 0.005 | 0.125 | Cyclin D1 inhibitor | 0.091 0.011 DBMET01678 0.098 0.008 DBMET01679 | ||
| 0.145 | 0.028 | 0.16 | Protein kinase C mu inhibitor | 0.152 0.025 DBMET01678 0.16 0.022 DBMET01679 | DBMET01679 | |
| 0.122 | 0.006 | 0.122 | Phosphodiesterase 2A inhibitor | 0.093 0.01 DBMET01678 0.097 0.009 DBMET01679 | ||
| 0.125 | 0.011 | 0.125 | 5 Hydroxytryptamine 5A antagonist | 0.074 0.027 DBMET01678 0.091 0.018 DBMET01679 | ||
| 0.143 | 0.03 | 0.143 | Gastric antisecretory | 0.106 0.059 DBMET01678 0.113 0.05 DBMET01679 | ||
| 0.126 | 0.014 | 0.126 | Benzodiazepine agonist | 0.082 0.037 DBMET01678 0.091 0.031 DBMET01679 | ||
| 0.126 | 0.014 | 0.129 | Phosphodiesterase III inhibitor | 0.129 0.013 DBMET01678 0.1 0.023 DBMET01679 | DBMET01678 | |
| 0.138 | 0.026 | 0.138 | Acetylcholine release stimulant | 0.102 0.084 DBMET01678 0.101 0.085 DBMET01679 | ||
| 0.128 | 0.019 | 0.14 | Phosphodiesterase 6D inhibitor | 0.125 0.021 DBMET01678 0.14 0.013 DBMET01679 | DBMET01679 | |
| 0.177 | 0.069 | 0.177 | MAP kinase kinase 5 inhibitor | |||
| 0.171 | 0.063 | 0.198 | Interleukin 6 antagonist | 0.198 0.042 DBMET01678 0.196 0.043 DBMET01679 | DBMET01678 | |
| 0.143 | 0.036 | 0.156 | Photosensitizer | 0.136 0.041 DBMET01678 0.156 0.028 DBMET01679 | DBMET01679 | |
| 0.132 | 0.025 | 0.154 | MAP kinase kinase 1 inhibitor | 0.121 0.034 DBMET01678 0.154 0.015 DBMET01679 | DBMET01679 | |
| 0.121 | 0.015 | 0.134 | Granulocyte macrophage colony stimulating factor agonist | 0.134 0.009 DBMET01678 0.098 0.038 DBMET01679 | DBMET01678 | |
| 0.152 | 0.048 | 0.222 | Interleukin 4 antagonist | 0.22 0.018 DBMET01678 0.222 0.017 DBMET01679 | DBMET01679 | |
| 0.129 | 0.026 | 0.144 | Pim-3 kinase inhibitor | 0.101 0.044 DBMET01678 0.144 0.02 DBMET01679 | DBMET01679 | |
| 0.142 | 0.04 | 0.203 | Interleukin 8 antagonist | 0.179 0.02 DBMET01678 0.203 0.012 DBMET01679 | DBMET01679 | |
| 0.114 | 0.013 | 0.116 | GABA A receptor antagonist | 0.073 0.024 DBMET01678 0.116 0.013 DBMET01679 | DBMET01679 | |
| 0.157 | 0.057 | 0.157 | Cytokine production inhibitor | 0.126 0.083 DBMET01678 0.107 0.104 DBMET01679 | ||
| 0.13 | 0.03 | 0.13 | Phosphodiesterase 7B inhibitor | 0.102 0.054 DBMET01678 0.098 0.059 DBMET01679 | ||
| 0.124 | 0.025 | 0.124 | Phosphodiesterase I inhibitor | 0.114 0.031 DBMET01678 0.104 0.04 DBMET01679 | ||
| 0.124 | 0.028 | 0.135 | Platelet growth factor antagonist | 0.135 0.024 DBMET01678 0.073 0.064 DBMET01679 | DBMET01678 | |
| 0.133 | 0.036 | 0.223 | Carbonic anhydrase III inhibitor | 0.197 0.017 DBMET01678 0.223 0.013 DBMET01679 | DBMET01679 | |
| 0.148 | 0.052 | 0.162 | Aurora-C kinase inhibitor | 0.142 0.062 DBMET01678 0.162 0.038 DBMET01679 | DBMET01679 | |
| 0.123 | 0.031 | 0.185 | Protein kinase C zeta inhibitor | 0.167 0.016 DBMET01678 0.185 0.013 DBMET01679 | DBMET01679 | |
| 0.105 | 0.015 | 0.116 | GABA receptor antagonist | 0.072 0.025 DBMET01678 0.116 0.013 DBMET01679 | DBMET01679 | |
| 0.17 | 0.08 | 0.185 | LIM domain kinase 1 inhibitor | 0.141 0.107 DBMET01678 0.185 0.07 DBMET01679 | DBMET01679 | |
| 0.104 | 0.014 | 0.104 | Potassium channel (ATP-sensitive) blocker | 0.077 0.031 DBMET01678 0.085 0.024 DBMET01679 | ||
| 0.15 | 0.061 | 0.185 | MAP kinase kinase 4 inhibitor | 0.152 0.058 DBMET01678 0.185 0.021 DBMET01679 | DBMET01679 | |
| 0.132 | 0.042 | 0.217 | GABA C receptor antagonist | 0.134 0.04 DBMET01678 0.217 0.01 DBMET01679 | DBMET01679 | |
| 0.126 | 0.036 | 0.126 | CDC-like kinase 3 inhibitor | 0.119 0.044 DBMET01678 0.12 0.043 DBMET01679 | ||
| 0.177 | 0.09 | 0.218 | Death-associated protein kinase 3 inhibitor | 0.192 0.079 DBMET01678 0.218 0.065 DBMET01679 | DBMET01679 | |
| 0.117 | 0.029 | 0.385 | Porphobilinogen synthase inhibitor | 0.126 0.026 DBMET01678 0.385 0.004 DBMET01679 | DBMET01679 | |
| 0.177 | 0.09 | 0.218 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.165 0.099 DBMET01678 0.218 0.067 DBMET01679 | DBMET01679 | |
| 0.152 | 0.066 | 0.174 | Glycogen synthase kinase-3 alpha inhibitor | 0.138 0.074 DBMET01678 0.174 0.051 DBMET01679 | DBMET01679 | |
| 0.144 | 0.061 | 0.144 | Nav1.6 sodium channel blocker | 0.117 0.101 DBMET01679 | ||
| 0.087 | 0.005 | 0.125 | GABA B receptor antagonist | 0.071 0.008 DBMET01678 0.125 0.004 DBMET01679 | DBMET01679 | |
| 0.092 | 0.011 | 0.092 | Phosphodiesterase 10A inhibitor | 0.057 0.023 DBMET01678 0.057 0.023 DBMET01679 | ||
| 0.092 | 0.011 | 0.092 | Phosphodiesterase X inhibitor | 0.057 0.023 DBMET01678 0.057 0.023 DBMET01679 | ||
| 0.116 | 0.035 | 0.116 | Phosphodiesterase IV inhibitor | 0.103 0.043 DBMET01678 | ||
| 0.179 | 0.099 | 0.256 | Neurotrophic factor enhancer | 0.247 0.04 DBMET01678 0.256 0.035 DBMET01679 | DBMET01679 | |
| 0.11 | 0.032 | 0.129 | Interleukin 5 antagonist | 0.103 0.038 DBMET01678 0.129 0.019 DBMET01679 | DBMET01679 | |
| 0.082 | 0.007 | 0.082 | Alpha 1L adrenoreceptor antagonist | 0.07 0.013 DBMET01678 0.055 0.03 DBMET01679 | ||
| 0.121 | 0.047 | 0.192 | Xanthine oxidase inhibitor | 0.187 0.022 DBMET01678 0.192 0.021 DBMET01679 | DBMET01679 | |
| 0.131 | 0.057 | 0.137 | MAP kinase 12 inhibitor | 0.104 0.093 DBMET01678 0.137 0.052 DBMET01679 | DBMET01679 | |
| 0.086 | 0.013 | 0.086 | Corticotropin releasing factor 2 receptor antagonist | 0.071 0.027 DBMET01679 | ||
| 0.114 | 0.041 | 0.147 | Protein kinase C delta inhibitor | 0.104 0.049 DBMET01678 0.147 0.023 DBMET01679 | DBMET01679 | |
| 0.125 | 0.053 | 0.145 | TRPA1 agonist | 0.11 0.071 DBMET01678 0.145 0.034 DBMET01679 | DBMET01679 | |
| 0.143 | 0.073 | 0.147 | Protein kinase (CK1) inhibitor | 0.147 0.07 DBMET01679 | DBMET01679 | |
| 0.082 | 0.012 | 0.082 | 5 Hydroxytryptamine 7 agonist | 0.063 0.027 DBMET01678 0.062 0.029 DBMET01679 | ||
| 0.076 | 0.007 | 0.076 | Inosine monophosphate dehydrogenase inhibitor | 0.06 0.01 DBMET01678 0.049 0.015 DBMET01679 | ||
| 0.094 | 0.028 | 0.107 | Cyclin-dependent kinase 4 inhibitor | 0.081 0.034 DBMET01678 0.107 0.023 DBMET01679 | DBMET01679 | |
| 0.124 | 0.059 | 0.124 | Glycogen synthase kinase-3 inhibitor | 0.116 0.064 DBMET01679 | ||
| 0.085 | 0.021 | 0.085 | 5 Hydroxytryptamine 6 antagonist | 0.051 0.047 DBMET01679 | ||
| 0.097 | 0.033 | 0.123 | D-Ala-D-Ala ligase inhibitor | 0.111 0.019 DBMET01678 0.123 0.012 DBMET01679 | DBMET01679 | |
| 0.094 | 0.031 | 0.129 | Check point kinase 1 inhibitor | 0.104 0.027 DBMET01678 0.129 0.018 DBMET01679 | DBMET01679 | |
| 0.199 | 0.135 | 0.209 | Transcription factor STAT3 inhibitor | 0.196 0.14 DBMET01678 0.209 0.122 DBMET01679 | DBMET01679 | |
| 0.08 | 0.017 | 0.085 | Transcription factor RelA inhibitor | 0.085 0.013 DBMET01678 0.072 0.026 DBMET01679 | DBMET01678 | |
| 0.129 | 0.067 | 0.129 | Protein kinase (CK1) delta inhibitor | 0.125 0.069 DBMET01679 | ||
| 0.071 | 0.009 | 0.071 | Benzodiazepine inverse agonist | 0.056 0.018 DBMET01678 0.06 0.014 DBMET01679 | ||
| 0.099 | 0.037 | 0.133 | Alpha 2a adrenoreceptor antagonist | 0.133 0.026 DBMET01678 0.08 0.048 DBMET01679 | DBMET01678 | |
| 0.084 | 0.022 | 0.125 | Protein kinase C eta inhibitor | 0.092 0.019 DBMET01678 0.125 0.011 DBMET01679 | DBMET01679 | |
| 0.085 | 0.024 | 0.122 | Protein kinase C beta inhibitor | 0.085 0.023 DBMET01678 0.122 0.007 DBMET01679 | DBMET01679 | |
| 0.103 | 0.042 | 0.103 | Polo-like kinase-1 inhibitor | 0.094 0.054 DBMET01678 0.082 0.078 DBMET01679 | ||
| 0.064 | 0.003 | 0.064 | Imidazoline I1 receptor antagonist | 0.025 0.01 DBMET01678 0.04 0.005 DBMET01679 | ||
| 0.129 | 0.069 | 0.132 | Antibacterial (Helicobacter pylori) | 0.132 0.064 DBMET01678 0.125 0.074 DBMET01679 | DBMET01678 | |
| 0.142 | 0.081 | 0.142 | MAP kinase 3 inhibitor | 0.128 0.112 DBMET01678 0.137 0.092 DBMET01679 | ||
| 0.099 | 0.039 | 0.147 | I kappa B kinase inhibitor | 0.086 0.053 DBMET01678 0.147 0.017 DBMET01679 | DBMET01679 | |
| 0.091 | 0.031 | 0.126 | Dopamine agonist | 0.125 0.019 DBMET01678 0.126 0.019 DBMET01679 | DBMET01679 | |
| 0.117 | 0.059 | 0.117 | Nav1.5 sodium channel blocker | |||
| 0.095 | 0.038 | 0.097 | CYP2A6 inhibitor | 0.097 0.037 DBMET01679 | DBMET01679 | |
| 0.085 | 0.028 | 0.085 | MAP kinase 7 inhibitor | 0.078 0.051 DBMET01678 | ||
| 0.113 | 0.058 | 0.113 | Aurora-A kinase inhibitor | 0.09 0.075 DBMET01679 | ||
| 0.111 | 0.055 | 0.111 | Platelet activating factor beta antagonist | 0.111 0.055 DBMET01678 | ||
| 0.103 | 0.048 | 0.127 | Interleukin 12 antagonist | 0.106 0.045 DBMET01678 0.127 0.023 DBMET01679 | DBMET01679 | |
| 0.152 | 0.097 | 0.175 | Neurotensin receptor agonist | 0.16 0.08 DBMET01678 0.175 0.055 DBMET01679 | DBMET01679 | |
| 0.116 | 0.062 | 0.116 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.093 | 0.04 | 0.129 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.096 0.038 DBMET01678 0.129 0.024 DBMET01679 | DBMET01679 | |
| 0.064 | 0.01 | 0.064 | Benzodiazepine antagonist | |||
| 0.112 | 0.059 | 0.112 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.116 | 0.064 | 0.116 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.116 | 0.064 | 0.116 | Glycogen synthase kinase-3 beta inhibitor | 0.105 0.072 DBMET01679 | ||
| 0.079 | 0.027 | 0.079 | Aryl hydrocarbon receptor antagonist | 0.06 0.053 DBMET01678 0.071 0.036 DBMET01679 | ||
| 0.158 | 0.106 | 0.185 | Non-steroidal antiinflammatory agent | 0.185 0.083 DBMET01678 0.147 0.118 DBMET01679 | DBMET01678 | |
| 0.093 | 0.042 | 0.137 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.133 0.024 DBMET01678 0.137 0.023 DBMET01679 | DBMET01679 | |
| 0.085 | 0.034 | 0.12 | MAP kinase kinase 7 inhibitor | 0.095 0.017 DBMET01678 0.12 0.004 DBMET01679 | DBMET01679 | |
| 0.108 | 0.058 | 0.144 | Beta glucuronidase inhibitor | 0.143 0.028 DBMET01678 0.144 0.028 DBMET01679 | DBMET01679 | |
| 0.067 | 0.019 | 0.067 | H+/K+-transporting ATPase inhibitor | 0.051 0.035 DBMET01678 0.054 0.032 DBMET01679 | ||
| 0.169 | 0.122 | 0.262 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.262 0.075 DBMET01678 0.166 0.125 DBMET01679 | DBMET01678 | |
| 0.16 | 0.112 | 0.195 | MAP kinase kinase 2 inhibitor | 0.152 0.119 DBMET01678 0.195 0.085 DBMET01679 | DBMET01679 | |
| 0.051 | 0.004 | 0.051 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.044 0.005 DBMET01678 0.033 0.007 DBMET01679 | ||
| 0.077 | 0.031 | 0.077 | Glutamate (mGluR7) antagonist | |||
| 0.101 | 0.055 | 0.122 | Breast cancer-resistant protein inhibitor | 0.122 0.038 DBMET01678 | DBMET01678 | |
| 0.193 | 0.147 | 0.303 | Lipoxygenase inhibitor | 0.303 0.07 DBMET01678 0.243 0.105 DBMET01679 | DBMET01678 | |
| 0.173 | 0.128 | 0.205 | ErbB-1 antagonist | 0.205 0.084 DBMET01678 0.161 0.151 DBMET01679 | DBMET01678 | |
| 0.14 | 0.096 | 0.142 | Polo-like kinase-3 inhibitor | 0.125 0.117 DBMET01678 0.142 0.093 DBMET01679 | DBMET01679 | |
| 0.065 | 0.021 | 0.065 | Pregnane X receptor antagonist | 0.065 0.021 DBMET01678 0.064 0.023 DBMET01679 | ||
| 0.068 | 0.025 | 0.15 | Alpha tubulin antagonist | 0.15 0.009 DBMET01678 0.059 0.032 DBMET01679 | DBMET01678 | |
| 0.136 | 0.093 | 0.146 | Heat shock protein 70 antagonist | 0.146 0.055 DBMET01678 0.146 0.055 DBMET01679 | DBMET01679 | |
| 0.095 | 0.052 | 0.106 | Alpha 2 adrenoreceptor antagonist | 0.106 0.044 DBMET01678 | DBMET01678 | |
| 0.136 | 0.095 | 0.171 | Cyclin-dependent kinase 8 inhibitor | 0.171 0.06 DBMET01679 | DBMET01679 | |
| 0.109 | 0.068 | 0.109 | Activin receptor-like kinase 4 inhibitor | 0.103 0.079 DBMET01678 0.104 0.077 DBMET01679 | ||
| 0.139 | 0.099 | 0.205 | Heat shock protein 90 alpha antagonist | 0.182 0.061 DBMET01678 0.205 0.046 DBMET01679 | DBMET01679 | |
| 0.056 | 0.017 | 0.056 | Glutamate (mGluR1a) antagonist | 0.043 0.026 DBMET01679 | ||
| 0.094 | 0.054 | 0.094 | Glutamate release inhibitor | |||
| 0.09 | 0.053 | 0.09 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.069 | 0.032 | 0.069 | Phosphodiesterase 1B inhibitor | 0.054 0.051 DBMET01678 | ||
| 0.064 | 0.027 | 0.064 | Ryanodine receptor antagonist | 0.062 0.031 DBMET01678 | ||
| 0.087 | 0.051 | 0.087 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.107 | 0.071 | 0.118 | MAP kinase 13 inhibitor | 0.118 0.057 DBMET01679 | DBMET01679 | |
| 0.065 | 0.029 | 0.065 | Protein kinase C theta inhibitor | 0.055 0.044 DBMET01678 0.063 0.031 DBMET01679 | ||
| 0.159 | 0.123 | 0.166 | Growth factor agonist | 0.155 0.13 DBMET01678 0.166 0.108 DBMET01679 | DBMET01679 | |
| 0.131 | 0.096 | 0.189 | Heat shock protein 90 antagonist | 0.189 0.044 DBMET01678 0.186 0.045 DBMET01679 | DBMET01678 | |
| 0.094 | 0.06 | 0.094 | Alpha 2d adrenoreceptor antagonist | 0.09 0.071 DBMET01679 | ||
| 0.056 | 0.021 | 0.065 | Phosphodiesterase 3B inhibitor | 0.065 0.018 DBMET01678 0.051 0.024 DBMET01679 | DBMET01678 | |
| 0.209 | 0.174 | 0.241 | Vasodilator, coronary | 0.241 0.143 DBMET01678 | DBMET01678 | |
| 0.145 | 0.111 | 0.168 | ATPase inhibitor | 0.168 0.074 DBMET01678 0.158 0.088 DBMET01679 | DBMET01678 | |
| 0.119 | 0.085 | 0.144 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.144 0.068 DBMET01679 | DBMET01679 | |
| 0.089 | 0.056 | 0.101 | Insulin growth factor antagonist | 0.101 0.046 DBMET01678 | DBMET01678 | |
| 0.069 | 0.035 | 0.141 | Beta tubulin antagonist | 0.141 0.013 DBMET01678 | DBMET01678 | |
| 0.067 | 0.034 | 0.067 | Protein kinase C iota inhibitor | 0.062 0.038 DBMET01678 0.064 0.037 DBMET01679 | ||
| 0.068 | 0.035 | 0.076 | TRPA1 antagonist | 0.076 0.028 DBMET01679 | DBMET01679 | |
| 0.081 | 0.048 | 0.081 | Nicotinic alpha4beta2 receptor antagonist | 0.071 0.06 DBMET01679 | ||
| 0.059 | 0.027 | 0.059 | Nicotinic alpha3beta2 receptor antagonist | 0.058 0.029 DBMET01679 | ||
| 0.071 | 0.04 | 0.071 | Fibroblast growth factor 2 antagonist | 0.06 0.052 DBMET01678 | ||
| 0.085 | 0.054 | 0.088 | Insulin like growth factor 1 antagonist | 0.088 0.052 DBMET01678 | DBMET01678 | |
| 0.086 | 0.055 | 0.097 | Myeloperoxidase inhibitor | 0.097 0.038 DBMET01678 0.097 0.039 DBMET01679 | DBMET01679 | |
| 0.042 | 0.012 | 0.042 | Melatonin receptor 1A agonist | |||
| 0.08 | 0.05 | 0.08 | Fibroblast growth factor 3 antagonist | |||
| 0.073 | 0.043 | 0.112 | Cyclin B3 inhibitor | 0.086 0.035 DBMET01678 0.112 0.024 DBMET01679 | DBMET01679 | |
| 0.068 | 0.039 | 0.068 | 5 Hydroxytryptamine 2A agonist | |||
| 0.119 | 0.091 | 0.123 | Protein kinase (CK1) gamma inhibitor | 0.123 0.087 DBMET01679 | DBMET01679 | |
| 0.193 | 0.165 | 0.229 | 5 Hydroxytryptamine uptake stimulant | 0.229 0.104 DBMET01678 0.209 0.134 DBMET01679 | DBMET01678 | |
| 0.047 | 0.019 | 0.059 | Alpha 1d adrenoreceptor agonist | 0.059 0.011 DBMET01679 | DBMET01679 | |
| 0.206 | 0.179 | 0.206 | Ca(v)3.3 blocker | |||
| 0.158 | 0.131 | 0.187 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.187 0.085 DBMET01678 0.183 0.089 DBMET01679 | DBMET01678 | |
| 0.063 | 0.035 | 0.063 | Phosphodiesterase 1A inhibitor | 0.057 0.049 DBMET01679 | ||
| 0.102 | 0.075 | 0.102 | Polo-like kinase-4 inhibitor | |||
| 0.101 | 0.075 | 0.127 | EphA2 antagonist | 0.127 0.048 DBMET01678 | DBMET01678 | |
| 0.063 | 0.037 | 0.063 | Potassium channel (Ca-activated) blocker | |||
| 0.134 | 0.109 | 0.149 | Protein kinase (CK1) gamma 3 inhibitor | 0.13 0.113 DBMET01678 0.149 0.091 DBMET01679 | DBMET01679 | |
| 0.106 | 0.081 | 0.126 | Microtubule formation inhibitor | 0.126 0.055 DBMET01678 0.101 0.089 DBMET01679 | DBMET01678 | |
| 0.063 | 0.038 | 0.063 | Bombesin 1 receptor agonist | 0.058 0.043 DBMET01679 | ||
| 0.037 | 0.013 | 0.037 | Nicotinic alpha3beta4 receptor agonist | 0.037 0.012 DBMET01679 | ||
| 0.064 | 0.04 | 0.064 | Phosphodiesterase 1C inhibitor | 0.058 0.053 DBMET01678 0.06 0.048 DBMET01679 | ||
| 0.066 | 0.042 | 0.066 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.109 | 0.086 | 0.181 | Glutamate receptor antagonist | 0.181 0.033 DBMET01679 | DBMET01679 | |
| 0.034 | 0.012 | 0.034 | Nicotinic alpha4beta2 receptor agonist | 0.031 0.016 DBMET01679 | ||
| 0.184 | 0.162 | 0.217 | Transcription factor STAT inhibitor | 0.182 0.165 DBMET01678 0.217 0.115 DBMET01679 | DBMET01679 | |
| 0.123 | 0.101 | 0.138 | CC chemokine 6 receptor antagonist | 0.13 0.072 DBMET01678 0.138 0.046 DBMET01679 | DBMET01679 | |
| 0.056 | 0.035 | 0.057 | Myc inhibitor | 0.057 0.033 DBMET01679 | DBMET01679 | |
| 0.112 | 0.09 | 0.112 | DNA repair enzyme inhibitor | 0.109 0.098 DBMET01678 0.11 0.094 DBMET01679 | ||
| 0.056 | 0.035 | 0.056 | Toll-Like receptor 8 antagonist | |||
| 0.074 | 0.055 | 0.074 | Glutamate (mGluR) antagonist | |||
| 0.034 | 0.015 | 0.034 | Cyclin E2 inhibitor | 0.028 0.021 DBMET01679 | ||
| 0.097 | 0.079 | 0.13 | 5 Hydroxytryptamine 3A agonist | 0.13 0.048 DBMET01679 | DBMET01679 | |
| 0.069 | 0.05 | 0.069 | Glutamate (mGluR group I) antagonist | |||
| 0.047 | 0.03 | 0.048 | Phosphodiesterase 6C inhibitor | 0.048 0.026 DBMET01679 | DBMET01679 | |
| 0.071 | 0.054 | 0.085 | Phosphodiesterase 4D inhibitor | 0.085 0.044 DBMET01678 | DBMET01678 | |
| 0.082 | 0.065 | 0.082 | mTOR complex 2 inhibitor | 0.079 0.073 DBMET01678 0.081 0.067 DBMET01679 | ||
| 0.054 | 0.037 | 0.064 | Protein kinase C epsilon inhibitor | 0.047 0.045 DBMET01678 0.064 0.028 DBMET01679 | DBMET01679 | |
| 0.1 | 0.084 | 0.108 | Protein kinase (CK1) gamma 2 inhibitor | 0.094 0.091 DBMET01678 0.108 0.076 DBMET01679 | DBMET01679 | |
| 0.057 | 0.041 | 0.057 | Glutamate (mGluR1) antagonist | |||
| 0.139 | 0.122 | 0.139 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.078 | 0.062 | 0.098 | Protein kinase A inhibitor | 0.079 0.061 DBMET01678 0.098 0.047 DBMET01679 | DBMET01679 | |
| 0.065 | 0.049 | 0.065 | Acetylcholine M5 receptor agonist | |||
| 0.063 | 0.048 | 0.063 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.071 | 0.057 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.054 DBMET01679 | DBMET01679 | |
| 0.149 | 0.135 | 0.177 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.177 0.098 DBMET01678 | DBMET01678 | |
| 0.073 | 0.059 | 0.088 | GABA B receptor agonist | 0.083 0.035 DBMET01678 0.088 0.028 DBMET01679 | DBMET01679 | |
| 0.055 | 0.042 | 0.091 | Xanthine dehydrogenase inhibitor | 0.082 0.023 DBMET01678 0.091 0.019 DBMET01679 | DBMET01679 | |
| 0.035 | 0.022 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.025 | 0.013 | 0.025 | Phosphodiesterase 6A inhibitor | 0.023 0.018 DBMET01679 | ||
| 0.023 | 0.012 | 0.023 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.055 | 0.044 | 0.057 | Cyclin E inhibitor | 0.057 0.043 DBMET01679 | DBMET01679 | |
| 0.115 | 0.104 | 0.132 | Protein kinase (CK1) gamma 1 inhibitor | 0.132 0.086 DBMET01679 | DBMET01679 | |
| 0.094 | 0.084 | 0.159 | Cystathionine beta-synthase inhibitor | 0.139 0.046 DBMET01678 0.159 0.037 DBMET01679 | DBMET01679 | |
| 0.042 | 0.031 | 0.047 | Glutamate (mGluR group III) agonist | 0.047 0.026 DBMET01679 | DBMET01679 | |
| 0.038 | 0.029 | 0.038 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.03 | 0.02 | 0.03 | Thiazolidinedione | |||
| 0.094 | 0.085 | 0.094 | 5 Hydroxytryptamine antagonist | |||
| 0.033 | 0.025 | 0.039 | Glutamate (mGluR4) agonist | 0.039 0.016 DBMET01679 | DBMET01679 | |
| 0.027 | 0.02 | 0.027 | Hedgehog signaling activator | |||
| 0.051 | 0.044 | 0.051 | Bromodomain-containing protein 4 inhibitor | |||
| 0.077 | 0.07 | 0.118 | Histamine N-methyltransferase inhibitor | 0.118 0.031 DBMET01679 | DBMET01679 | |
| 0.04 | 0.034 | 0.04 | Histamine H2 receptor agonist | |||
| 0.05 | 0.045 | 0.05 | Phosphodiesterase 4C inhibitor | |||
| 0.13 | 0.125 | 0.329 | Amyloid beta aggregation inhibitor | 0.329 0.039 DBMET01678 0.179 0.089 DBMET01679 | DBMET01678 | |
| 0.045 | 0.04 | 0.047 | Cyclin E1 inhibitor | 0.047 0.039 DBMET01679 | DBMET01679 | |
| 0.044 | 0.041 | 0.044 | Transforming growth factor beta 1 antagonist | |||
| 0.119 | 0.116 | 0.146 | Hemostatic | 0.142 0.078 DBMET01678 0.146 0.073 DBMET01679 | DBMET01679 | |
| 0.036 | 0.034 | 0.036 | Vanilloid 3 antagonist | |||
| 0.021 | 0.019 | 0.039 | Dopamine D1 agonist | 0.039 0.005 DBMET01678 0.035 0.007 DBMET01679 | DBMET01678 | |
| 0.107 | 0.105 | 0.123 | Alkaline phosphatase inhibitor | 0.123 0.082 DBMET01678 0.116 0.091 DBMET01679 | DBMET01678 | |
| 0.072 | 0.07 | 0.072 | ALK inhibitor | |||
| 0.03 | 0.028 | 0.03 | Melatonin 2 agonist | |||
| 0.042 | 0.042 | 0.044 | Phosphodiesterase 4A inhibitor | 0.044 0.04 DBMET01678 | DBMET01678 | |
| 0.18 | 0.179 | 0.183 | Gastrin inhibitor | 0.183 0.174 DBMET01679 | DBMET01679 | |
| 0.113 | 0.113 | 0.128 | Mannose-6-phosphate isomerase inhibitor | 0.128 0.088 DBMET01678 0.119 0.102 DBMET01679 | DBMET01678 | |
| 0.059 | 0.059 | 0.228 | Phenylalanine 4-hydroxylase inhibitor | 0.086 0.033 DBMET01678 0.228 0.005 DBMET01679 | DBMET01679 | |
| 0.063 | 0.064 | 0.096 | Histone deacetylase stimulant | 0.077 0.047 DBMET01678 0.096 0.03 DBMET01679 | DBMET01679 | |
| 0.063 | 0.064 | 0.096 | Histone deacetylase SIRT1 stimulant | 0.077 0.047 DBMET01678 0.096 0.03 DBMET01679 | DBMET01679 | |
| 0.084 | 0.085 | 0.158 | Topoisomerase I inhibitor | 0.158 0.038 DBMET01678 0.133 0.049 DBMET01679 | DBMET01678 | |
| 0.04 | 0.041 | 0.043 | Poly(ADP-ribose) polymerase inhibitor | 0.043 0.034 DBMET01679 | DBMET01679 | |
| 0.06 | 0.061 | 0.076 | Protein kinase C alpha inhibitor | 0.076 0.038 DBMET01679 | DBMET01679 | |
| 0.084 | 0.085 | 0.109 | Urease inhibitor | 0.109 0.057 DBMET01678 0.106 0.061 DBMET01679 | DBMET01678 | |
| 0.075 | 0.077 | 0.08 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.08 0.072 DBMET01679 | DBMET01679 | |
| 0.123 | 0.126 | 0.152 | Interferon gamma antagonist | 0.152 0.075 DBMET01678 0.147 0.081 DBMET01679 | DBMET01678 | |
| 0.047 | 0.051 | 0.062 | Cyclin B2 inhibitor | 0.05 0.047 DBMET01678 0.062 0.03 DBMET01679 | DBMET01679 | |
| 0.032 | 0.036 | 0.034 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.034 0.032 DBMET01679 | DBMET01679 | |
| 0.043 | 0.048 | 0.078 | Topoisomerase II beta inhibitor | 0.078 0.014 DBMET01678 0.072 0.016 DBMET01679 | DBMET01678 | |
| 0.067 | 0.072 | 0.093 | Keratolytic | 0.092 0.036 DBMET01678 0.093 0.035 DBMET01679 | DBMET01679 | |
| 0.039 | 0.044 | 0.048 | Chemokine receptor agonist | 0.048 0.037 DBMET01679 | DBMET01679 | |
| 0.185 | 0.193 | 0.277 | Caspase 3 stimulant | 0.277 0.092 DBMET01678 | DBMET01678 | |
| 0.034 | 0.041 | 0.044 | Liver X receptor alpha agonist | 0.038 0.034 DBMET01678 0.044 0.025 DBMET01679 | DBMET01679 | |
| 0.011 | 0.02 | 0.016 | CXC chemokine 4 receptor agonist | 0.016 0.009 DBMET01679 | DBMET01679 | |
| 0.048 | 0.058 | 0.063 | Cyclin-dependent kinase 6 inhibitor | 0.063 0.038 DBMET01679 | DBMET01679 | |
| 0.06 | 0.07 | 0.093 | Na+ K+ transporting ATPase inhibitor | 0.079 0.051 DBMET01678 0.093 0.038 DBMET01679 | DBMET01679 | |
| 0.075 | 0.085 | 0.105 | CC chemokine 5 receptor agonist | 0.105 0.017 DBMET01679 | DBMET01679 | |
| 0.032 | 0.043 | 0.054 | CDK5/p25 inhibitor | 0.054 0.018 DBMET01679 | DBMET01679 | |
| 0.057 | 0.068 | 0.067 | CDK2/cyclin E2 inhibitor | 0.067 0.052 DBMET01679 | DBMET01679 | |
| 0.096 | 0.109 | 0.111 | Cyclooxygenase 3 inhibitor | 0.111 0.088 DBMET01678 | DBMET01678 | |
| 0.083 | 0.097 | 0.098 | Carbonic anhydrase XV inhibitor | 0.09 0.083 DBMET01678 0.098 0.07 DBMET01679 | DBMET01679 | |
| 0.066 | 0.081 | 0.104 | Carbonic anhydrase VI inhibitor | 0.103 0.037 DBMET01678 0.104 0.037 DBMET01679 | DBMET01679 | |
| 0.046 | 0.061 | 0.097 | Fatty acid synthase inhibitor | 0.061 0.034 DBMET01678 0.097 0.012 DBMET01679 | DBMET01679 | |
| 0.025 | 0.041 | 0.032 | Liver X receptor beta agonist | 0.032 0.026 DBMET01679 | DBMET01679 | |
| 0.043 | 0.06 | 0.056 | Cyclin B inhibitor | 0.056 0.038 DBMET01679 | DBMET01679 | |
| 0.044 | 0.062 | 0.072 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.072 0.025 DBMET01679 | DBMET01679 | |
| 0.019 | 0.037 | 0.036 | Liver X receptor beta antagonist | 0.036 0.015 DBMET01679 | DBMET01679 | |
| 0.047 | 0.065 | 0.062 | Cyclin B1 inhibitor | 0.062 0.041 DBMET01679 | DBMET01679 | |
| 0.055 | 0.074 | 0.066 | Beta 3 adrenoreceptor antagonist | 0.062 0.05 DBMET01678 0.066 0.042 DBMET01679 | DBMET01679 | |
| 0.052 | 0.072 | 0.066 | CDC7 inhibitor | 0.066 0.048 DBMET01679 | DBMET01679 | |
| 0.051 | 0.071 | 0.078 | I kappa B kinase 2 inhibitor | 0.078 0.024 DBMET01679 | DBMET01679 | |
| 0.089 | 0.109 | 0.102 | RET inhibitor | 0.102 0.095 DBMET01678 | DBMET01678 | |
| 0.094 | 0.115 | 0.106 | Acetylcholinesterase inhibitor | 0.106 0.096 DBMET01678 | DBMET01678 | |
| 0.08 | 0.101 | 0.126 | Protein kinase (CK2) alpha inhibitor | 0.12 0.062 DBMET01678 0.126 0.058 DBMET01679 | DBMET01679 | |
| 0.114 | 0.136 | 0.151 | Arachidonic acid antagonist | 0.148 0.091 DBMET01678 0.151 0.088 DBMET01679 | DBMET01679 | |
| 0.028 | 0.05 | 0.035 | Protein kinase C beta I inhibitor | 0.035 0.017 DBMET01679 | DBMET01679 | |
| 0.052 | 0.075 | 0.123 | Histidine decarboxylase inhibitor | 0.096 0.034 DBMET01678 0.123 0.025 DBMET01679 | DBMET01679 | |
| 0.075 | 0.099 | 0.106 | Mediator release inhibitor | 0.093 0.079 DBMET01678 0.106 0.063 DBMET01679 | DBMET01679 | |
| 0.032 | 0.056 | 0.047 | Geranyltranstransferase inhibitor | 0.047 0.026 DBMET01679 | DBMET01679 | |
| 0.138 | 0.162 | 0.352 | Free radical scavenger | 0.352 0.038 DBMET01678 0.244 0.071 DBMET01679 | DBMET01678 | |
| 0.017 | 0.042 | 0.026 | Glucagon receptor antagonist | 0.026 0.024 DBMET01679 | DBMET01679 | |
| 0.11 | 0.136 | 0.152 | Hexokinase inhibitor | 0.152 0.076 DBMET01679 | DBMET01679 | |
| 0.039 | 0.066 | 0.052 | Beta 1 adrenoreceptor antagonist | 0.05 0.046 DBMET01678 0.052 0.044 DBMET01679 | DBMET01679 | |
| 0.037 | 0.064 | 0.051 | Aromatase inhibitor | 0.051 0.047 DBMET01679 | DBMET01679 | |
| 0.062 | 0.09 | 0.111 | Androgen antagonist | 0.079 0.067 DBMET01678 0.111 0.039 DBMET01679 | DBMET01679 | |
| 0.06 | 0.088 | 0.085 | Macrophage migration inhibitory factor inhibitor | 0.085 0.045 DBMET01678 0.083 0.047 DBMET01679 | DBMET01678 | |
| 0.125 | 0.153 | 0.14 | Ca2+-transporting ATPase inhibitor | 0.14 0.075 DBMET01679 | DBMET01679 | |
| 0.038 | 0.067 | 0.055 | Dopamine beta hydroxylase inhibitor | 0.055 0.022 DBMET01679 | DBMET01679 | |
| 0.069 | 0.099 | 0.091 | Pim-1 kinase inhibitor | 0.091 0.066 DBMET01679 | DBMET01679 | |
| 0.082 | 0.115 | 0.117 | Alkylator | 0.117 0.071 DBMET01678 0.101 0.087 DBMET01679 | DBMET01678 | |
| 0.086 | 0.121 | 0.1 | Electron transport complex I inhibitor | 0.1 0.083 DBMET01678 | DBMET01678 | |
| 0.092 | 0.127 | 0.11 | Ribosomal protein S6 kinase inhibitor | 0.11 0.103 DBMET01679 | DBMET01679 | |
| 0.156 | 0.192 | 0.218 | DNA synthesis inhibitor | 0.177 0.158 DBMET01678 0.218 0.097 DBMET01679 | DBMET01679 | |
| 0.138 | 0.176 | 0.195 | Spasmolytic | 0.195 0.124 DBMET01678 0.166 0.149 DBMET01679 | DBMET01678 | |
| 0.082 | 0.121 | 0.139 | DOPA decarboxylase inhibitor | 0.114 0.053 DBMET01678 0.139 0.028 DBMET01679 | DBMET01679 | |
| 0.045 | 0.086 | 0.059 | 5 Hydroxytryptamine 3 agonist | 0.059 0.05 DBMET01679 | DBMET01679 | |
| 0.029 | 0.069 | 0.069 | AMPA receptor antagonist | 0.069 0.021 DBMET01679 | DBMET01679 | |
| 0.046 | 0.088 | 0.061 | CDK1/cyclin B1 inhibitor | 0.061 0.059 DBMET01679 | DBMET01679 | |
| 0.116 | 0.16 | 0.22 | DNA methylase inhibitor | 0.22 0.066 DBMET01678 | DBMET01678 | |
| 0.113 | 0.157 | 0.214 | DNA methyltransferase I inhibitor | 0.214 0.062 DBMET01678 | DBMET01678 | |
| 0.04 | 0.085 | 0.062 | Botulinum neurotoxin type A inhibitor | 0.062 0.034 DBMET01679 | DBMET01679 | |
| 0.101 | 0.146 | 0.13 | Vanilloid 1 agonist | 0.13 0.067 DBMET01678 | DBMET01678 | |
| 0.108 | 0.155 | 0.151 | Adenylate cyclase stimulant | 0.151 0.062 DBMET01678 0.15 0.062 DBMET01679 | DBMET01678 | |
| 0.044 | 0.093 | 0.063 | Prostaglandin-E synthase inhibitor | 0.063 0.058 DBMET01679 | DBMET01679 | |
| 0.061 | 0.11 | 0.087 | Cyclin-dependent kinase 1 inhibitor | 0.087 0.077 DBMET01679 | DBMET01679 | |
| 0.057 | 0.109 | 0.079 | Glycine receptor antagonist | 0.079 0.059 DBMET01679 | DBMET01679 | |
| 0.064 | 0.116 | 0.115 | Prolactin inhibitor | 0.115 0.042 DBMET01679 | DBMET01679 | |
| 0.043 | 0.096 | 0.059 | Beta adrenoreceptor antagonist | 0.059 0.058 DBMET01678 | DBMET01678 | |
| 0.109 | 0.162 | 0.14 | Melanin inhibitor | 0.14 0.097 DBMET01678 0.127 0.119 DBMET01679 | DBMET01678 | |
| 0.068 | 0.123 | 0.126 | Ferrochelatase inhibitor | 0.126 0.05 DBMET01679 | DBMET01679 | |
| 0.055 | 0.111 | 0.101 | Potassium channel (Ca-activated) activator | 0.101 0.054 DBMET01679 | DBMET01679 | |
| 0.164 | 0.221 | 0.235 | Insulysin inhibitor | 0.199 0.159 DBMET01678 0.235 0.111 DBMET01679 | DBMET01679 | |
| 0.177 | 0.234 | 0.207 | Toll-Like receptor 7 agonist | 0.207 0.193 DBMET01678 | DBMET01678 | |
| 0.031 | 0.089 | 0.102 | Alcohol oxidase inhibitor | 0.102 0.018 DBMET01679 | DBMET01679 | |
| 0.175 | 0.235 | 0.208 | Toll-Like receptor agonist | 0.208 0.192 DBMET01678 | DBMET01678 | |
| 0.058 | 0.118 | 0.107 | Protein kinase (CK2) inhibitor | 0.085 0.078 DBMET01678 0.107 0.058 DBMET01679 | DBMET01679 | |
| 0.072 | 0.135 | 0.104 | Mucolytic | 0.104 0.072 DBMET01678 | DBMET01678 | |
| 0.08 | 0.144 | 0.128 | Aldehyde dehydrogenase inhibitor | 0.128 0.063 DBMET01679 | DBMET01679 | |
| 0.04 | 0.104 | 0.062 | Purinergic P2X1 antagonist | 0.062 0.041 DBMET01679 | DBMET01679 | |
| 0.153 | 0.218 | 0.207 | Cholesterol antagonist | 0.182 0.181 DBMET01678 0.207 0.158 DBMET01679 | DBMET01679 | |
| 0.028 | 0.094 | 0.046 | Beta 2 adrenoreceptor antagonist | 0.046 0.042 DBMET01679 | DBMET01679 | |
| 0.02 | 0.087 | 0.032 | Protein kinase C beta II inhibitor | 0.032 0.024 DBMET01679 | DBMET01679 | |
| 0.061 | 0.128 | 0.191 | Creatine kinase inhibitor | 0.099 0.061 DBMET01678 0.191 0.012 DBMET01679 | DBMET01679 | |
| 0.065 | 0.134 | 0.143 | Topoisomerase II inhibitor | 0.143 0.053 DBMET01678 0.119 0.068 DBMET01679 | DBMET01678 | |
| 0.117 | 0.188 | 0.161 | Succinate dehydrogenase inhibitor | 0.161 0.094 DBMET01678 0.138 0.136 DBMET01679 | DBMET01678 | |
| 0.039 | 0.116 | 0.061 | Heat shock protein 90 beta antagonist | 0.061 0.038 DBMET01678 0.055 0.049 DBMET01679 | DBMET01678 | |
| 0.085 | 0.163 | 0.109 | Protein kinase stimulant | 0.109 0.106 DBMET01678 | DBMET01678 | |
| 0.142 | 0.221 | 0.244 | 12-Lipoxygenase inhibitor | 0.244 0.112 DBMET01678 0.202 0.15 DBMET01679 | DBMET01678 | |
| 0.06 | 0.142 | 0.081 | NADH dehydrogenase inhibitor | 0.081 0.073 DBMET01679 | DBMET01679 | |
| 0.067 | 0.151 | 0.091 | AMP-activated protein kinase stimulant | 0.091 0.084 DBMET01679 | DBMET01679 | |
| 0.064 | 0.149 | 0.079 | Estrogen-related receptor beta agonist | 0.079 0.07 DBMET01679 | DBMET01679 | |
| 0.039 | 0.126 | 0.067 | CXC chemokine receptor antagonist | 0.067 0.054 DBMET01679 | DBMET01679 | |
| 0.041 | 0.128 | 0.084 | Topoisomerase II alpha inhibitor | 0.084 0.05 DBMET01678 0.067 0.064 DBMET01679 | DBMET01678 | |
| 0.059 | 0.146 | 0.126 | GABA C receptor agonist | 0.126 0.046 DBMET01679 | DBMET01679 | |
| 0.057 | 0.148 | 0.086 | ATPase (Vacuolar H+) inhibitor | 0.086 0.064 DBMET01678 | DBMET01678 | |
| 0.096 | 0.188 | 0.165 | Nitric oxide antagonist | 0.165 0.084 DBMET01678 | DBMET01678 | |
| 0.053 | 0.145 | 0.081 | Estrogen receptor alpha antagonist | 0.081 0.048 DBMET01679 | DBMET01679 | |
| 0.021 | 0.114 | 0.031 | Protein kinase (CK2) beta inhibitor | 0.031 0.029 DBMET01679 | DBMET01679 | |
| 0.117 | 0.215 | 0.301 | Antioxidant | 0.301 0.061 DBMET01678 0.224 0.099 DBMET01679 | DBMET01678 | |
| 0.063 | 0.162 | 0.126 | Amylase inhibitor | 0.126 0.077 DBMET01678 | DBMET01678 | |
| 0.059 | 0.164 | 0.107 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.107 0.094 DBMET01679 | DBMET01679 | |
| 0.02 | 0.125 | 0.047 | NMDA receptor subunit 3B antagonist | 0.047 0.027 DBMET01679 | DBMET01679 | |
| 0.047 | 0.159 | 0.111 | Alcohol dehydrogenase inhibitor | 0.111 0.041 DBMET01679 | DBMET01679 | |
| 0.066 | 0.184 | 0.091 | Adenylate kinase inhibitor | 0.091 0.085 DBMET01679 | DBMET01679 | |
| 0.042 | 0.161 | 0.081 | Adrenaline agonist | 0.081 0.056 DBMET01679 | DBMET01679 | |
| 0.112 | 0.232 | 0.142 | Catenin beta inhibitor | 0.142 0.127 DBMET01679 | DBMET01679 | |
| 0.05 | 0.178 | 0.096 | UDP-glucose 4-epimerase inhibitor | 0.096 0.065 DBMET01679 | DBMET01679 | |
| 0.015 | 0.144 | 0.044 | Dopamine D5 agonist | 0.044 0.023 DBMET01679 | DBMET01679 | |
| 0.025 | 0.156 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.052 0.04 DBMET01679 | DBMET01679 | |
| 0.052 | 0.186 | 0.089 | Anabolic | 0.089 0.081 DBMET01679 | DBMET01679 | |
| 0.065 | 0.202 | 0.119 | Toll-Like receptor 2 antagonist | 0.119 0.079 DBMET01678 | DBMET01678 | |
| 0.075 | 0.217 | 0.106 | Transcription factor STAT6 inhibitor | 0.106 0.091 DBMET01679 | DBMET01679 | |
| 0.041 | 0.185 | 0.094 | 5-Lipoxygenase inhibitor | 0.094 0.069 DBMET01678 | DBMET01678 | |
| 0.081 | 0.226 | 0.157 | NOS3 expression enhancer | 0.132 0.094 DBMET01678 0.157 0.066 DBMET01679 | DBMET01679 | |
| 0.029 | 0.174 | 0.079 | Glutamate decarboxylase inhibitor | 0.079 0.045 DBMET01679 | DBMET01679 | |
| 0.042 | 0.205 | 0.084 | Bronchodilator | 0.084 0.081 DBMET01678 | DBMET01678 | |
| 0.015 | 0.194 | 0.033 | Estrogen-related receptor beta antagonist | 0.033 0.021 DBMET01679 | DBMET01679 | |
| 0.047 | 0.242 | 0.16 | Lipid peroxidase inhibitor | 0.16 0.062 DBMET01678 0.117 0.097 DBMET01679 | DBMET01678 | |
| 0.092 | 0.288 | 0.14 | Phospholipase C inhibitor | 0.14 0.128 DBMET01679 | DBMET01679 | |
| 0.13 | 0.326 | 0.218 | Apoptosis antagonist | 0.218 0.158 DBMET01678 | DBMET01678 | |
| 0.04 | 0.243 | 0.105 | Chelator | 0.105 0.07 DBMET01678 0.1 0.077 DBMET01679 | DBMET01678 | |
| 0.053 | 0.261 | 0.136 | Estrogen antagonist | 0.136 0.031 DBMET01679 | DBMET01679 | |
| 0.041 | 0.265 | 0.123 | Estrogen receptor beta antagonist | 0.123 0.028 DBMET01679 | DBMET01679 | |
| 0.007 | 0.271 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.02 DBMET01678 | DBMET01678 | |
| 0.023 | 0.302 | 0.14 | M18 aspartyl aminopeptidase inhibitor | 0.14 0.057 DBMET01678 | DBMET01678 | |
| 0.141 | 0.434 | 0.281 | Antiinflammatory | 0.281 0.234 DBMET01678 | DBMET01678 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |